34 related articles for article (PubMed ID: 19728856)
1. Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort.
Linder R; Rönmark E; Pourazar J; Behndig AF; Blomberg A; Lindberg A
Respir Res; 2018 Apr; 19(1):64. PubMed ID: 29650051
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer.
Pellegrini P; Contasta I; Berghella AM; Gargano E; Mammarella C; Adorno D
Cancer Immunol Immunother; 2000 Sep; 49(7):388-94. PubMed ID: 10999465
[TBL] [Abstract][Full Text] [Related]
3. The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer.
Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240178
[TBL] [Abstract][Full Text] [Related]
4. A Disintegrin and Metalloproteinase (ADAM) Family-Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
Łukaszewicz-Zając M; Pączek S; Mroczko B
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565436
[TBL] [Abstract][Full Text] [Related]
5. Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma.
Xie W; Sun G; Zhu J; Wang H; Han Z; Wang P
Front Genet; 2022; 13():860611. PubMed ID: 35559040
[TBL] [Abstract][Full Text] [Related]
6. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review.
Calanzani N; Druce PE; Snudden C; Milley KM; Boscott R; Behiyat D; Saji S; Martinez-Gutierrez J; Oberoi J; Funston G; Messenger M; Emery J; Walter FM
Adv Ther; 2021 Feb; 38(2):793-834. PubMed ID: 33306189
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
Zhang Y; Qin L; Ma X; Wang Y; Wu Y; Jiang J
Dis Markers; 2020; 2020():8831466. PubMed ID: 33005257
[TBL] [Abstract][Full Text] [Related]
8. The Fibrinogen to Mean Platelet Volume Ratio Can Predict Overall Survival of Patients with Non-Metastatic Gastric Cancer.
Song S; Cong X; Li F; Xue Y
J Gastric Cancer; 2018 Dec; 18(4):368-378. PubMed ID: 30607300
[TBL] [Abstract][Full Text] [Related]
9. Mean platelet volume provides beneficial diagnostic and prognostic information for patients with resectable gastric cancer.
Shen XM; Xia YY; Lian L; Zhou C; Li XL; Han SG; Zheng Y; Gong FR; Tao M; Mao ZQ; Li W
Oncol Lett; 2016 Oct; 12(4):2501-2506. PubMed ID: 27703523
[TBL] [Abstract][Full Text] [Related]
10. Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer.
Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Gong FR; Tao M; Li W
Oncol Lett; 2015 Dec; 10(6):3419-3424. PubMed ID: 26788144
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum tumor marker levels in gastric cancer.
Polat E; Duman U; Duman M; Derya Peker K; Akyuz C; Fatih Yasar N; Uzun O; Akbulut S; Birol Bostanci E; Yol S
Pak J Med Sci; 2014 Jan; 30(1):145-9. PubMed ID: 24639849
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma.
Cheng D; Kong H; Li Y
Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):503-9. PubMed ID: 23749058
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.
Liao M; Tong P; Zhao J; Zhang Y; Li Z; Wang J; Feng X; Hu M; Pan Y
Pathol Oncol Res; 2012 Apr; 18(2):397-403. PubMed ID: 21909684
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of genes involved in gastric tumorigenesis.
Rajkumar T; Vijayalakshmi N; Gopal G; Sabitha K; Shirley S; Raja UM; Ramakrishnan SA
Cancer Cell Int; 2010 Nov; 10():45. PubMed ID: 21092330
[TBL] [Abstract][Full Text] [Related]
15. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of gastric cancer patients.
Jelski W; Orywal K; Laniewska M; Szmitkowski M
Clin Exp Med; 2010 Dec; 10(4):215-9. PubMed ID: 20454995
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients.
Mroczko B; Groblewska M; Łukaszewicz-Zajac M; Bandurski R; Kedra B; Szmitkowski M
Clin Chem Lab Med; 2009; 47(9):1133-9. PubMed ID: 19728856
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Mroczko B; Lukaszewicz-Zajac M; Wereszczynska-Siemiatkowska U; Groblewska M; Gryko M; Kedra B; Jurkowska G; Szmitkowski M
Pancreas; 2009 Aug; 38(6):613-8. PubMed ID: 19629003
[TBL] [Abstract][Full Text] [Related]
19. Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
Groblewska M; Mroczko B; Kozlowski M; Niklinski J; Laudanski J; Szmitkowski M
Folia Histochem Cytobiol; 2012; 50(4):590-8. PubMed ID: 23264224
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
